Patents Assigned to Prevention, L.L.C.
  • Publication number: 20140378522
    Abstract: The present invention relates to methods for preventing the development of cancer or neurodegenerative diseases by administering N-Acetylcysteine (NAC), melatonin, or a combination thereof. The present invention also relates to methods for diagnosing cancer and/or neurdegenerative disease by detecting or determining the amount of dopamine metabolites, 4-CE, 2-CE, methylation of CE or CE-Q conjugates.
    Type: Application
    Filed: January 13, 2014
    Publication date: December 25, 2014
    Applicant: Prevention, L.L.C.
    Inventors: Ercole L. Cavalieri, Eleanor G. Rogan
  • Patent number: 8629174
    Abstract: The present invention relates to methods for preventing the development of cancer or neurodegenerative diseases by administering N-Acetylcysteine (NAC), melatonin, or a combination thereof. The present invention also relates to methods for diagnosing cancer and/or neurdegenerative disease by detecting or determining the amount of dopamine metabolites, 4-CE, 2-CE, methylation of CE or CE-Q conjugates.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: January 14, 2014
    Assignee: Prevention L.L.C.
    Inventors: Ercole L. Cavalieri, Eleanor G. Rogan
  • Publication number: 20090312391
    Abstract: The present invention relates to methods for preventing the development of cancer or neurodegenerative diseases by administering N-Acetylcysteine (NAC), melatonin, or a combination thereof. The present invention also relates to methods for diagnosing cancer and/or neurdegenerative disease by detecting or determining the amount of dopamine metabolites, 4-CE, 2-CE, methylation of CE or CE-Q conjugates.
    Type: Application
    Filed: July 31, 2009
    Publication date: December 17, 2009
    Applicant: Prevention, L.L.C.
    Inventors: Ercole L. Cavalieri, Eleanor Rogan